NanoViricides (NYSE-A:NNVC) will present at the Life Science Executive Partnering (LSX) Congress 2025 in Boston on September 17 at 12:30pm.
Dr Anil Diwan, president and executive chairman, will provide updates on the company’s antiviral drug pipeline and platform technologies.
He will also participate in partnering sessions and be available for additional meetings during the event.